Literature DB >> 31746104

Performance of multiplex serology in discriminating active vs past Helicobacter pylori infection in a primarily African American population in the southeastern United States.

Julia Butt1,2, William J Blot3, Martha J Shrubsole4, Matthew G Varga5, Laura H Hendrix6, Sydnee Crankshaw1, Tim Waterboer2, Michael Pawlita2, Meira Epplein1.   

Abstract

PURPOSE: To feasibly analyze associations of Helicobacter pylori (H. pylori) with disease in large cohort studies, assays are needed to assess H. pylori prevalence in existing biospecimens. However, serology has traditionally been unable to distinguish active from past infection. We sought to determine the sensitivity of seropositivity to H. pylori proteins to detect active infection.
METHODS: We measured antibody responses to 13 H. pylori proteins using multiplex serology in serum samples of a training (n = 78) and validation set (n = 49) collected concurrently from patients undergoing urea breath test (UBT). To determine sensitivity of seropositivity to H. pylori proteins for active infection, a cutoff was applied to achieve 90% specificity. Antibody levels were retested in a subset of participants (n = 16) 6 months after baseline.
RESULTS: With a specificity of 91%, seropositivity to H. pylori proteins VacA, GroEl, HcpC, and HP1564 ascertained active infection from 100% to 75% sensitivity. Positivity to a combination of these proteins (≥2 out of the 4) resulted in specificity of 90% and sensitivity of 100%. The validation set replicated results from the training set. Among those participants with successful H. pylori eradication after baseline, antibody levels decreased significantly for VacA, HcpC, and HP1564 when assessed 6 months later.
CONCLUSION: Utilizing the cutoffs for seropositivity established through comparison with UBT, seropositivity to ≥2 of the H. pylori proteins VacA, GroEl, HcpC, and HP1564 determines active H. pylori infection at high specificity and sensitivity and may approximate the prevalence of active H. pylori infection in large cohorts.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  eradication; multiplex serology; urea breath test

Mesh:

Substances:

Year:  2019        PMID: 31746104      PMCID: PMC6940508          DOI: 10.1111/hel.12671

Source DB:  PubMed          Journal:  Helicobacter        ISSN: 1083-4389            Impact factor:   5.753


  21 in total

1.  Helicobacter pylori multiplex serology.

Authors:  Angelika Michel; Tim Waterboer; Manfred Kist; Michael Pawlita
Journal:  Helicobacter       Date:  2009-12       Impact factor: 5.753

Review 2.  BK and JC virus: a review.

Authors:  Michelle Pinto; Simon Dobson
Journal:  J Infect       Date:  2013-10-08       Impact factor: 6.072

3.  Southern community cohort study: establishing a cohort to investigate health disparities.

Authors:  Lisa B Signorello; Margaret K Hargreaves; Mark D Steinwandel; Wei Zheng; Qiuyin Cai; David G Schlundt; Maciej S Buchowski; Carolyne W Arnold; Joseph K McLaughlin; William J Blot
Journal:  J Natl Med Assoc       Date:  2005-07       Impact factor: 1.798

Review 4.  Extragastric Diseases and Helicobacter pylori.

Authors:  Francesco Franceschi; Antonio Gasbarrini; Stergios A Polyzos; Jannis Kountouras
Journal:  Helicobacter       Date:  2015-09       Impact factor: 5.753

5.  Secular trends in Helicobacter pylori seroprevalence in adults in the United States: evidence for sustained race/ethnic disparities.

Authors:  Yonatan H Grad; Marc Lipsitch; Allison E Aiello
Journal:  Am J Epidemiol       Date:  2011-11-15       Impact factor: 4.897

6.  Prediagnostic circulating polyomavirus antibody levels and risk of non-Hodgkin lymphoma.

Authors:  Lauren R Teras; Dana E Rollison; Michael Pawlita; Angelika Michel; Jennifer L Blase; Martina Willhauck-Fleckenstein; Susan M Gapstur
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12-08       Impact factor: 4.254

7.  Dynamics of human papillomavirus serology in women followed up for 36 months after pregnancy.

Authors:  Stina Syrjänen; Tim Waterboer; Marja Sarkola; Kristina Michael; Marjut Rintala; Kari Syrjänen; Seija Grenman; Michael Pawlita
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

8.  Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.

Authors:  Julia Butt; Matthew G Varga; William J Blot; Lauren Teras; Kala Visvanathan; Loïc Le Marchand; Christopher Haiman; Yu Chen; Ying Bao; Howard D Sesso; Sylvia Wassertheil-Smoller; Gloria Y F Ho; Lesley E Tinker; Richard M Peek; John D Potter; Timothy L Cover; Laura H Hendrix; Li-Ching Huang; Terry Hyslop; Caroline Um; Francine Grodstein; Mingyang Song; Anne Zeleniuch-Jacquotte; Sonja Berndt; Allan Hildesheim; Tim Waterboer; Michael Pawlita; Meira Epplein
Journal:  Gastroenterology       Date:  2018-10-06       Impact factor: 22.682

Review 9.  Diagnosis of Helicobacter pylori infection.

Authors:  Sabine Skrebinska; Francis Mégraud; Emilie Bessède
Journal:  Helicobacter       Date:  2018-09       Impact factor: 5.753

10.  Validation of a Novel Immunoline Assay for Patient Stratification according to Virulence of the Infecting Helicobacter pylori Strain and Eradication Status.

Authors:  Luca Formichella; Laura Romberg; Hannelore Meyer; Christian Bolz; Michael Vieth; Michael Geppert; Gereon Göttner; Christina Nölting; Wolfgang Schepp; Arne Schneider; Kurt Ulm; Petra Wolf; Ingrid Lisanne Holster; Ernst J Kuipers; Bernd Birkner; Erwin Soutschek; Markus Gerhard
Journal:  J Immunol Res       Date:  2017-05-30       Impact factor: 4.818

View more
  5 in total

Review 1.  What Is New in Helicobacter pylori Diagnosis. An Overview.

Authors:  Maria Pina Dore; Giovanni Mario Pes
Journal:  J Clin Med       Date:  2021-05-13       Impact factor: 4.241

Review 2.  Helicobacter pylori Outer Membrane Vesicles and Extracellular Vesicles from Helicobacter pylori-Infected Cells in Gastric Disease Development.

Authors:  María Fernanda González; Paula Díaz; Alejandra Sandoval-Bórquez; Daniela Herrera; Andrew F G Quest
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

3.  Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala.

Authors:  Christian S Alvarez; Andrea A Florio; Julia Butt; Alvaro Rivera-Andrade; María F Kroker-Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D Freedman; Barry I Graubard; Mariana Lazo; Eliseo Guallar; John D Groopman; Manuel Ramírez-Zea; Katherine A McGlynn
Journal:  Helicobacter       Date:  2020-10-02       Impact factor: 5.182

4.  The Durham Initiative for Stomach Health (DISH): a pilot community-based Helicobacter pylori education and screening study.

Authors:  Sydnee Crankshaw; Julia Butt; Jennifer M Gierisch; Nadine J Barrett; Sabrena Mervin-Blake; Kevin Oeffinger; Steven Patierno; Valarie Worthy; Ronald Godbee; Meira Epplein
Journal:  BMC Gastroenterol       Date:  2020-08-06       Impact factor: 3.067

5.  Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer.

Authors:  Meira Epplein; Loïc Le Marchand; Timothy L Cover; Mingyang Song; William J Blot; Richard M Peek; Lauren R Teras; Kala Visvanathan; Yu Chen; Howard D Sesso; Anne Zeleniuch-Jacquotte; Sonja I Berndt; John D Potter; Marc D Ryser; Christopher A Haiman; Sylvia Wassertheil-Smoller; Lesley F Tinker; Tim Waterboer; Julia Butt
Journal:  Microorganisms       Date:  2020-10-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.